Maintenance of glycaemic control with the evening administration of a long acting sulphonylurea in male type 2 diabetic patients undertaking the Ramadan fast

International Journal of Clinical Practice

Volumn 64, Issue 8, 2010, Pages 1090-1094

  Zargar, A H ^a   Siraj, M ^b   Jawa, A A ^c   Hasan, M ^d   Mahtab, H ^e  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

^b Owaisi Hospital and Research Center ^*  (India)

^c KING EDWARD MEDICAL UNIVERSITY   (Pakistan)

^d MAYO HOSPITAL   (Pakistan)

^e National Health Care Network   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

GLICLAZIDE; GLUCOSE;

ADULT; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; EVENING DOSAGE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; DELAYED-ACTION PREPARATIONS; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; FASTING; FEMALE; GLICLAZIDE; HUMANS; HYPOGLYCEMIC AGENTS; ISLAM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77953828850     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02262.x     Document Type: Article

References (14)

1. Salti I, Benard E, Detournay B et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries. Diabetes Care 2004 27 : 2306 2311.
2. Aadil N, Houti IE, Moussamih S. Drug intake during Ramadan. BMJ 2004 329 : 778 782.
3. Gharbi M, Akrout M, Zouari B. Food intake during and outside Ramadan (in French). East Medterr Health J 2003 9 : 131 140.
4. Yarahmadi SH, Larijani B, Bastanhagh MH et al. Metabolic and clinical effects of Ramadan fasting in patients with type II diabetes. J Coll Physicians Surg Pak 2003 13 : 329 332.
5. Aslam M, Healey MA. Compliance and drug therapy in Moslem patients. J Clin Hosp Pharm 1986 11 : 321 325.
6. Aslam M, Assad A. Drug regimens and fasting during Ramadan: a survey in Kuwait. Public Health 1986 100 : 49 53.
7. Guillausseau PJ, Greb W. 24-Hour glycemic profile in type 2 diabetic patients treated with gliclazide modified release once daily. Diabetes Metab (Paris) 2001 27 : 133 137.
8. Schernthaner G, Grimaldi A, Di Mario U et al. GUIDE study: double blind comparison of once daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest 2004 34 : 535 542.
9. Diabetes and Ramadan Advisory Board. International medical recommendations for Muslim subjects with diabetes mellitus who fast during the month of Ramadan. Clin Diabetes (Middle East Edition) 2004 3 : 143 145.
10. Belkhadir J, Ghomari H El, Kocker N, Mikou A, Nasciri M, Sabri M. Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide. BMJ 1993 307 : 292 295.
11. The glimepiride in Ramadan (GLIRA) study group. The efficacy and safety of glimepiride in the management of type 2 diabetes in Muslim patients during Ramadan. Diabetes Care 2005 28 : 421 422.
12. Sari R, Balci MK, Akbas SH, Avci B. The effects of diet, sulphonylurea, and repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res 2004 30 : 169 177.
13. Vasan S, Thomas N, Bharani et al. A double-blind, randomized, multicenter study evaluating the effects of pioglitazone in fasting Muslim subjects during Ramadan. Int J Diabetes Dev Ctries 2006 26 : 71 6.
14. Dills GD, Schneider J, The Glimepiride/Glyburide Research group. Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Horm Metab Res 1966 28 : 426 429.